Maxygen Inc

Formerly NASDAQ: MAXY
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.13
from 10-K 1 page Maxygen, Inc. Summary of Non-Employee Director Compensation
12/34/56
EX-10.2
from 8-K 20 pages Assignment and Assumption of Lease and Third Amendment to Lease
12/34/56
EX-10.1
from 8-K 23 pages Assignment and Assumption of Lease and Seventh Amendment to Lease
12/34/56
EX-10.8
from 10-Q 1 page Maxygen, Inc. Summary of Non-Employee Director Compensation
12/34/56
EX-10.7
from 10-Q 9 pages Maxygen, Inc. Consulting Agreement
12/34/56
EX-10.6
from 10-Q 9 pages Maxygen, Inc. 2006 Equity Incentive Plan Form of Notice of Grant of Contingent Performance Units
12/34/56
EX-10.5
from 10-Q 14 pages Maxygen, Inc. 2006 Equity Incentive Plan Form of Notice of Grant of Restricted Stock
12/34/56
EX-10.4
from 10-Q 1 page Waverley Associates, Inc. [Address] Attn: Isaac Stein Re: Amendment of Consulting Agreement Dear Isaac: Yours Sincerely, /S/ Ernest Mario Ernest Mario Chairman of Maxygen Compensation Committee Understood and Agreed by Waverley Associates, Inc. Signature: /S/ Isaac Stein Date: October 13, 2009
12/34/56
EX-10.2
from 8-K 14 pages Maxygen, Inc. Form of Change of Control Agreement
12/34/56
EX-10.1
from 8-K 4 pages On Behalf of Maxygen, Inc., I Am Pleased to Extend to You This Offer of Employment With Maxygen in Connection With Your Appointment by the Maxygen Board of Directors as Chief Executive Officer and Chief Financial Officer. Your Employment With Maxygen Is Effective Today, With Your Appointment as Chief Executive Officer and Chief Financial Officer to Be Effective as of October 1, 2009. Your Position Is a Full-Time, Exempt Position. Your Employment Is Subject to Proof of Your Legal Right to Work in the United States, and to Your Completing the Immigration and Naturalization Service Employment Eligibility Verification Form I-9. Compensation
12/34/56
EX-10.5
from 8-K 19 pages Perseid Therapeutics LLC 2009 Equity Incentive Plan
12/34/56
EX-10.4
from DEFA14A 10 pages Your Position With the Maxygen Subsidiary Will Be Chief Executive Officer and President, Reporting to the Board of Managers (Or Equivalent Body, if the Entity Is Not a Limited Liability Company) of the Maxygen Subsidiary (The “Board”). Your Position Is a Full-Time, Exempt, Executive Officer Position. Compensation
12/34/56
EX-10.4
from 8-K 10 pages Your Position With the Maxygen Subsidiary Will Be Chief Executive Officer and President, Reporting to the Board of Managers (Or Equivalent Body, if the Entity Is Not a Limited Liability Company) of the Maxygen Subsidiary (The “Board”). Your Position Is a Full-Time, Exempt, Executive Officer Position. Compensation
12/34/56
EX-10.3
from DEFA14A 14 pages Maxygen, Inc. Amended and Restated Change of Control Agreement
12/34/56
EX-10.3
from 8-K 14 pages Maxygen, Inc. Amended and Restated Change of Control Agreement
12/34/56
EX-10.2
from DEFA14A 30 pages Maxygen, Inc. Retention Agreement
12/34/56
EX-10.2
from 8-K 30 pages Maxygen, Inc. Retention Agreement
12/34/56
EX-10.1
from DEFA14A 32 pages Maxygen, Inc. Amended and Restated Change of Control Agreement
12/34/56
EX-10.1
from 8-K 32 pages Maxygen, Inc. Amended and Restated Change of Control Agreement
12/34/56
EX-10.19.1
from 10-K 1 page This Letter Will Reflect the Agreement of Maxygen, Inc. (“Company”) and Michael Rabson (“Consultant”) to Amend That Certain Consulting Agreement Entered Into Between Consultant and the Company, Effective 1st April 2008 (The “Agreement”). All Capitalized Terms Under This Letter Amendment Shall Have the Same Meanings as Those Ascribed in the Agreement. the Company and the Consultant Hereby Amend the Agreement as Follows
12/34/56